|

Angiotensin II Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Giapreza (synthetic human angiotensin II)

Other1 trial

Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
Phase 3

San Francisco, California1 trial

Angiotensin II in Liver Transplantation

University of California, San Francisco

Phase 2/3

Towson, Maryland1 trial

ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

University of Maryland St. Joseph Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.